Acadian Asset Management’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-96,548
Closed -$158K 1880
2024
Q3
$158K Buy
+96,548
New +$158K ﹤0.01% 1446
2024
Q2
Sell
-239,962
Closed -$316K 1825
2024
Q1
$316K Sell
239,962
-319,343
-57% -$421K ﹤0.01% 1101
2023
Q4
$837K Sell
559,305
-197,945
-26% -$296K ﹤0.01% 908
2023
Q3
$1.11M Buy
757,250
+159,973
+27% +$235K ﹤0.01% 834
2023
Q2
$1.5M Buy
597,277
+486,503
+439% +$1.22M 0.01% 779
2023
Q1
$164K Sell
110,774
-33,904
-23% -$50.2K ﹤0.01% 1297
2022
Q4
$201K Buy
144,678
+109,072
+306% +$152K ﹤0.01% 1282
2022
Q3
$112K Sell
35,606
-42,134
-54% -$133K ﹤0.01% 1335
2022
Q2
$270K Buy
+77,740
New +$270K ﹤0.01% 1126
2019
Q2
Sell
-2,011
Closed -$16K 1926
2019
Q1
$16K Buy
+2,011
New +$16K ﹤0.01% 1833
2018
Q1
Sell
-407
Closed -$97K 1742
2017
Q4
$97K Buy
+407
New +$97K ﹤0.01% 1103